- Home
- CLBT vs AGO Comparison
CLBT vs AGO Comparison
Compare CLBT & AGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLBT
- AGO
- Stock Information
- Founded
- CLBT 1999
- AGO 2003
- Country
- CLBT Israel
- AGO Bermuda
- Employees
- CLBT N/A
- AGO N/A
- Industry
- CLBT Computer Software: Prepackaged Software
- AGO Property-Casualty Insurers
- Sector
- CLBT Technology
- AGO Finance
- Exchange
- CLBT Nasdaq
- AGO Nasdaq
- Market Cap
- CLBT 3.9B
- AGO 3.9B
- IPO Year
- CLBT N/A
- AGO 2004
- Fundamental
- Price
- CLBT $18.51
- AGO $87.78
- Analyst Decision
- CLBT Strong Buy
- AGO Buy
- Analyst Count
- CLBT 5
- AGO 2
- Target Price
- CLBT $24.40
- AGO $98.50
- AVG Volume (30 Days)
- CLBT 1.4M
- AGO 305.9K
- Earning Date
- CLBT 11-12-2025
- AGO 11-06-2025
- Dividend Yield
- CLBT N/A
- AGO 1.55%
- EPS Growth
- CLBT N/A
- AGO N/A
- EPS
- CLBT 0.31
- AGO 8.00
- Revenue
- CLBT $455,903,000.00
- AGO $911,000,000.00
- Revenue This Year
- CLBT $19.44
- AGO N/A
- Revenue Next Year
- CLBT $16.78
- AGO N/A
- P/E Ratio
- CLBT $58.95
- AGO $10.94
- Revenue Growth
- CLBT 18.36
- AGO 5.08
- 52 Week Low
- CLBT $13.10
- AGO $74.09
- 52 Week High
- CLBT $26.30
- AGO $96.50
- Technical
- Relative Strength Index (RSI)
- CLBT 58.10
- AGO 67.84
- Support Level
- CLBT $14.98
- AGO $86.95
- Resistance Level
- CLBT $19.98
- AGO $88.60
- Average True Range (ATR)
- CLBT 0.65
- AGO 1.60
- MACD
- CLBT 0.18
- AGO 0.73
- Stochastic Oscillator
- CLBT 69.60
- AGO 92.35
About CLBT Cellebrite DI Ltd.
Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze, and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker.
About AGO Assured Guaranty Ltd.
Assured Guaranty Ltd. provides credit protection products to the United States and international public finance and structured finance markets and manages assets across collateralized loan obligations as well as opportunity funds and liquid funds that build on its corporate credit, asset-based finance, municipal, and healthcare experience. The company operates in two segments: the Insurance segment and the Asset Management segment. The majority of the revenue earned by the company is from the Insurance segment.